tradingkey.logo

Bioventus Inc

BVS
查看詳細走勢圖
8.510USD
+0.300+3.65%
收盤 02/06, 16:00美東報價延遲15分鐘
569.95M總市值
54.31本益比TTM

Bioventus Inc

8.510
+0.300+3.65%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.65%

5天

+7.31%

1月

+11.83%

6月

+22.80%

今年開始到現在

+14.38%

1年

-19.26%

查看詳細走勢圖

TradingKey Bioventus Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Bioventus Inc當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名13/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為15.00。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bioventus Inc評分

相關信息

行業排名
13 / 205
全市場排名
84 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
極度看空

Bioventus Inc亮點

亮點風險
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
估值高估
公司最新PE估值54.31,處於3年歷史高位
機構減倉
最新機構持股49.87M股,環比減少0.00%
HACAX持倉
明星投資者HACAX持倉,最新持倉19.50K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.49

分析師目標

基於 3 分析師
買入
評級
15.000
目標均價
+85.19%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bioventus Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bioventus Inc簡介

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
公司代碼BVS
公司Bioventus Inc
CEOClaypoole (Robert E)
網址https://www.bioventus.com/
KeyAI